GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » Issuance of Stock

Pharvaris NV (Pharvaris NV) Issuance of Stock : $373.70 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV Issuance of Stock?

Pharvaris NV's Issuance of Stock for the three months ended in Mar. 2024 was $0.21 Mil.

Pharvaris NV's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was $373.70 Mil.


Pharvaris NV Issuance of Stock Historical Data

The historical data trend for Pharvaris NV's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharvaris NV Issuance of Stock Chart

Pharvaris NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Stock
Get a 7-Day Free Trial 24.96 124.71 177.21 10.18 373.95

Pharvaris NV Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 69.43 0.12 303.94 0.21

Pharvaris NV Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $373.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharvaris NV Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharvaris NV (Pharvaris NV) Business Description

Traded in Other Exchanges
Address
Emmy Noetherweg 2, Leiden, NLD, 2333 BK
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.